Investor Relations |
|
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
Recent Releases
May 8, 2013
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
Apr 30, 2013
Questcor Reports First Quarter Financial Results
Apr 15, 2013
Questcor to Report First Quarter Results on April 30, 2013
Events & Presentations
May 14, 2013 at 4:20 PM PT
Bank of America Merrill Lynch 2013 Healthcare Conference
Apr 30, 2013 at 4:30 PM ET
Q1 2013 Questcor Pharmaceuticals, Inc. Earnings Conference
| Investor Presentation |
|---|
|
May 2013
Bank of America Merrill Lynch 2013 Healthcare Conference
|
| Stock Chart | |
|---|---|
|
|
|
| Stock Quote | |
| Questcor Pharmaceuticals, Inc. | |
| Price: | 38.85 |
| Change: | + 1.51 |
| Day High: | 39.19 |
| Day Low: | 37.06 |
| Volume: | 621,700 |
| Delayed at least 20 minutes. Provided by eSignal. |
|
Transfer Agent
Computershare Trust Co., Inc.Phone 303-262-0600
Corporate Counsel
Stradling Yocca Carlson & RauthNewport Beach, CA